Pavel Anzenbacher Selected Research

Pavel Anzenbacher Research Topics

Disease

9	Neoplasms (Cancer) 02/2019 - 01/2004
3	Obesity 06/2017 - 07/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2019 - 01/2015
2	Body Weight (Weight, Body) 01/2016 - 07/2015
1	Colitis 12/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2022
1	Protozoan Infections 01/2022
1	Liver Failure 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Osteoporosis 02/2019
1	Autistic Disorder (Autism) 02/2019
1	Weight Gain 12/2018
1	Morphine Dependence 10/2017
1	Hypercholesterolemia 07/2017
1	Angina Pectoris 11/2016
1	Venous Insufficiency 01/2015
1	Chronic Hepatitis B 08/2014
1	Infections 08/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2011
1	Tics (Tic) 12/2003
1	Liver Diseases (Liver Disease) 11/2002

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2022 - 12/2003
5	EnzymesIBA 06/2017 - 06/2010
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2022 - 04/2013
3	CytochromesIBA 01/2020 - 09/2011
3	Anthocyanins (Anthocyanin)IBA 12/2018 - 04/2013
3	Sodium Glutamate (Accent)IBA 06/2017 - 07/2015
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2015 - 06/2004
2	XenobioticsIBA 01/2020 - 01/2011
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 06/2017 - 09/2011
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2013 - 04/2013
2	NitrosaminesIBA 12/2012 - 10/2005
1	Metronidazole (Metric)FDA LinkGeneric 01/2022
1	ProdrugsIBA 01/2020
1	sulforaphaneIBA 02/2019
1	Heroin (Diamorphine)IBA 10/2017
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2017
1	Atorvastatin (Lipitor)FDA Link 07/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2017
1	cytochrome P-450 CYP2C subfamilyIBA 06/2017
1	Proteins (Proteins, Gene)FDA Link 06/2017
1	1,4-dihydropyridine (dihydropyridine)IBA 11/2016
1	Antihypertensive Agents (Antihypertensives)IBA 11/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2016
1	TeaIBA 02/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Insulin (Novolin)FDA Link 07/2015
1	LeptinIBA 07/2015
1	CoumarinsIBA 01/2015
1	AntioxidantsIBA 01/2015
1	AnticoagulantsIBA 01/2015
1	Warfarin (Coumadin)FDA LinkGeneric 01/2015
1	coumarinIBA 01/2015
1	Tenofovir (Viread)FDA Link 08/2014
1	adefovir dipivoxil (Hepsera)FDA Link 08/2014
1	NucleotidesIBA 08/2014
1	delphinidinIBA 04/2013
1	pelargonidinIBA 04/2013
1	malvidinIBA 04/2013
1	petunidinIBA 04/2013
1	peonidinIBA 04/2013
1	cyanidinIBA 04/2013
1	cucurbit(n)uril (cucurbituril)IBA 12/2012
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 09/2011
1	Cytochrome P-450 CYP2C19IBA 09/2011
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 09/2011
1	Cytochrome P-450 CYP2C8IBA 09/2011
1	Cytochrome P-450 CYP2C9IBA 09/2011
1	Cytochrome P-450 CYP3AIBA 09/2011
1	hydroxypropyl methacrylateIBA 09/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2011
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2011
1	N-(2-hydroxypropyl)methacrylamideIBA 09/2011
1	SolventsIBA 10/2005
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2005
1	Docetaxel (Taxotere)FDA Link 06/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2004
1	Complementary DNA (cDNA)IBA 06/2004
1	PorphyrinsIBA 01/2004
1	Photosensitizing Agents (Photosensitizers)IBA 01/2004
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2004
1	Propafenone (Rythmol)FDA LinkGeneric 12/2003
1	SilymarinIBA 11/2002
1	Silybin (Lagosa)IBA 11/2002
1	FlavonolignansIBA 11/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020